GURUFOCUS.COM » STOCK LIST » Technology » Software » Core Scientific Inc (OTCPK:CORZQ) » Definitions » Debt-to-EBITDA

Core Scientific (Core Scientific) Debt-to-EBITDA : 0.64 (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Core Scientific Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Core Scientific's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $29.0 Mil. Core Scientific's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $626.8 Mil. Core Scientific's annualized EBITDA for the quarter that ended in Mar. 2024 was $1,019.0 Mil. Core Scientific's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 was 0.64.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Core Scientific's Debt-to-EBITDA or its related term are showing as below:

CORZQ' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -13.71   Med: -0.02   Max: 24.67
Current: 3.44

During the past 5 years, the highest Debt-to-EBITDA Ratio of Core Scientific was 24.67. The lowest was -13.71. And the median was -0.02.

CORZQ's Debt-to-EBITDA is ranked worse than
76.61% of 1616 companies
in the Software industry
Industry Median: 1.06 vs CORZQ: 3.44

Core Scientific Debt-to-EBITDA Historical Data

The historical data trend for Core Scientific's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Core Scientific Debt-to-EBITDA Chart

Core Scientific Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
-1.35 24.67 5.82 -0.02 -13.71

Core Scientific Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.46 0.24 -15.05 -2.69 0.64

Competitive Comparison of Core Scientific's Debt-to-EBITDA

For the Software - Infrastructure subindustry, Core Scientific's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Core Scientific's Debt-to-EBITDA Distribution in the Software Industry

For the Software industry and Technology sector, Core Scientific's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Core Scientific's Debt-to-EBITDA falls into.



Core Scientific Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Core Scientific's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(144.206 + 721.339) / -63.121
=-13.71

Core Scientific's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(28.97 + 626.765) / 1019
=0.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2024) EBITDA data.


Core Scientific  (OTCPK:CORZQ) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Core Scientific Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Core Scientific's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Core Scientific (Core Scientific) Business Description

Traded in Other Exchanges
Address
210 Barton Springs Road, Austin, TX, USA, 78704
Core Scientific Inc is engaged in Blockchain and AI Infrastructure, Digital Asset Self-Mining, Premium Hosting, Blockchain Technology, and Artificial Intelligence related services. The business operates in two segments being; Equipment Sales and Hosting which consists of blockchain infrastructure, third-party hosting business and equipment sales to customers. Mining segment consists of digital asset mining for its account. The blockchain business generates revenue from the sale of consumption-based contracts and by providing hosting services. The digital asset mining segment earns revenue from operating a firm's owned computer equipment as part of a pool of users that process transactions conducted on one or more blockchain networks. In exchange, it receives digital currency assets.
Executives
Adam Taylor Sullivan officer: President C/O CORE SCIENTIFIC, INC., 2407 S. CONGRESS AVENUE, AUSTIN TX 78704
Darin Feinstein director, 10 percent owner, officer: Chief Vision Officer 2800 NORTHUP WAY, SUITE 220, BELLEVUE WA 98004
Sterling Denise Marie Brucia officer: Chief Financial Officer C/O CORE SCIENTIFIC, INC., 201 BARTON SPRINGS ROAD, AUSTIN TX 78704
Matt Minnis director 2800 NORTHUP WAY, SUITE 220, BELLEVUE WA 98004
Brian Neville officer: Chief Accounting Officer C/O CORE SCIENTIFIC, INC., 2800 NORTHROP WAY, BELLEVUE WA 98004
Todd M Duchene officer: EVP, GC and Secretary 847 GIBRALTAR DR., MILPITAS CA 95035
Michael Trzupek officer: Chief Financial Officer 2800 NORTHUP WAY, SUITE 220, BELLEVUE WA 98004
Stacie Olivares director 2525 E. CAMELBACK RD., STE 850, PHOENIX AZ 85016
Jarvis V. Hollingsworth director 100 WEST HOUSTON STREET, SAN ANTONIO TX 78205
Michael J Levitt director, officer: Chief Executive Officer KAYNE ANDERSON CAPITAL ADVISORS, L.P., 1800 AVENUE OF THE STARS, 3RD FLOOR, LOS ANGELES CA 90067
Dr Kneeland Youngblood director C/O GAP, INC., 2 FOLSOM ST., SAN FRANCISCO CA 94105
John P Mcgarrity officer: General Counsel and Secretary 321 N. CLARK STREET, CHICAGO IL 60054
Sullivan Colleen director 420 EXECUTIVE SQUARE SUITE 300, LA JOLLA CA 92037
Theodore J Brombach 10 percent owner 321 N. CLARK STREET, CHICAGO IL 60054
Patrick C Eilers director, 10 percent owner, officer: Chief Executive Officer THREE FIRST NATIONAL PLAZA STE 3800, CHICAGO IL 60602

Core Scientific (Core Scientific) Headlines

From GuruFocus